Archive for the ‘Fate Therapeutics’ Category

Fate Therapeutics

August 16th, 2013 | Posted in 2013, Fate Therapeutics

Fate Therapeutics Inc – La Jolla:  Is a developer of stem-cell therapies.  Fate recently announced that have filed for an IPO (initial public offering) of stock .  The company is seeking to raise up to $69-million, according to the prospectus filed recently.

Fate Therapeutics

April 29th, 2010 | Posted in Fate Therapeutics

Fate Therapeutics, San Diego, announced a deal to buy the privately-held Canadian company, Verio Therapeutics.   The companies both specialize in using drugs to stimulate the body’s existing stem cells to promote tissue regeneration and repair and to treat disease. Fate said it would form a Canadian subsidiary to continue Verio’s discovery and development operations in […]